A Phase I/II Clinical Trial of "Off-the-shelf" NK Cell Administration in Combination With Allogeneic SCT to Decrease Disease Relapse in Patients With High-risk Myeloid Malignancies Undergoing Matched Related, Matched Unrelated, One Antigen Mismatched Unrelated, or Haploidentical Stem-cell Transplantation
Arms / Cohorts
Experimental:Cyclophosphamide
Accepting patients
Experimental:Mesna
Accepting patients
Experimental:Filgrastim
Accepting patients
Experimental:Melphalan
Accepting patients
Experimental:Fludarabine phosphate
Accepting patients
Experimental:Tacrolimus
Accepting patients
Experimental:Mycophenolate mofetil
Accepting patients
Experimental:Total Body Irradiation
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.